Return to Index
Screening for Benign Prostatic Hyperplasia (BPH)
The purpose of screening is early diagnosis and treatment. Screening tests are usually administered to people without current symptoms, but who may be at high risk for certain diseases or conditions.
The digital rectal exam can detect BPH. This involves your doctor inserting a gloved finger into the lower rectum. From here, your doctor can estimate the size of your prostate, identify some (but not all) cancers, and find anal diseases.
A prostate specific antigen (PSA) test may be done as a screening tool for prostate cancer (not for BPH). Unfortunately, men with prostate cancer or BPH can have high PSA levels. Other prostate conditions such as prostatitis can also lead to high PSA levels. More tests or studies may need to be done to determine that exact cause of the high PSA level.
American Urological Association (AUA) Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia. Available at: http://www.auanet.org/guidelines/benign-prostatic-hyperplasia-(2010-reviewed-and-validity-confirmed-2014). Accessed September 8, 2017.
Benign prostatic hyperplasia (BPH). EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T116944/Benign-prostatic-hyperplasia-BPH . Updated September 1, 2017. Accessed September 8, 2017.
Pearson R, Williams PM. Common questions about the diagnosis and management of benign prostatic hyperplasia. Am Fam Physician. 2014;90(11):769-774.
How is BPH diagnosed? American Urological Association Foundation website. Available at: http://www.urologyhealth.org/urologic-conditions/benign-prostatic-hyperplasia-%28bph%29/diagnosis. Accessed September 8, 2017.
- Reviewer: EBSCO Medical Review Board Adrienne Carmack, MD
- Review Date: 09/2018
- Update Date: 09/17/2014